OUR CBD STRENGTHS
Completed in Switzerland
Raw material Lineup
ISOLATE
CBD CBG CBN
DISTILATE
CBD CBG CBN CRD
GACP GMP
We can make proposals tailored to your needs
Compliance with laws and regulations
Each lot is checked by a third-party testing organization to ensure no THC is detected at a standard of 1 ppm, and through thorough quality control, IRIS SWISS is able to provide high-quality and reliable CBD raw materials.
CBD原料について
CBD Bulk Sales
IRIS SWISS ensures the stability and safety of its products by conducting regular inspections at its affiliated processing facilities. We exclusively use stems from organically cultivated hemp within Switzerland, transforming them into high-quality CBD materials. The entire process, from cultivation to raw material production, is completed within Switzerland. Moreover, to guarantee product safety, each batch undergoes rigorous testing by independent third-party laboratories to confirm the absence of THC. Through these measures, IRIS SWISS maintains the reliability of its products, providing customers with CBD materials they can use with confidence.
Completed in Switzerland
Completed in Switzerland
IRIS SWISSは、提携している加工工場に対して定期的に視察を行うことで、製品の品質安定性と安全性を
徹底して確保しています。
スイス国内の完全室内で有機栽培されたヘンプの茎のみを使用し、高品質のCBD原料に加工しています。
この一連のプロセスはすべてスイス国内で行われ、さらに製品の安全性を保証するために、出荷される
各ロットは第三者検査機関による厳格なテストを受け、THCが未検出であることを確認しています。
IRIS SWISSは製品の信頼性を保ちながら、皆様に安心して使用していただけるCBD原料を提供しています。
Compliance with safety standards
IRIS SWISS is committed to maintaining the highest standards of safety and quality, especially when exporting products to the Japanese market. As part of this commitment, in addition to the stringent inspections carried out within Switzerland, we conduct another round of independent third-party testing for THC non-detection before exporting our products to Japan. This dual testing process ensures that all CBD materials comply fully with Japanese regulations, offering an additional layer of reassurance to consumers. This rigorous quality control approach enables IRIS SWISS to continue supplying high-quality, trustworthy CBD products to the Japanese market. This method not only enhances the company's reliability but also maintains its competitive edge in the international business landscape.
日本市場への輸出に際しては法規の遵守の一環として、
スイス国内での厳格な検査に加え、日本へ輸出する前には
再度、第三者検査機関でTHC未検出の検査を行っています。
この二重の検査プロセスにより、輸入されるすべてのCBD原料が日本の法規制に完全に適合していることを保証し、消費者に対してさらなる安心を提供しています。
この徹底した品質管理により、IRIS SWISSは高品質で信頼できるCBD製品を日本市場に供給し続けています。
